Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Inhibin beta A (INHBA) (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This INHBA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 85-112 amino acids from the N-terminal region of human INHBA. |
Haptoglobin (HP) (Center) rabbit polyclonal antibody, Aff - Purified
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | KLH conjugated synthetic peptide between 296-322 amino acids from the Central region of Human Haptoglobin |
Fibromodulin (FMOD) (C-term) rabbit polyclonal antibody, Aff - Purified
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | KLH conjugated synthetic peptide between 343~373 amino acids from the C-terminal region of Human Fibromodulin. |
Dopamine beta Hydroxylase (DBH) (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | KLH conjugated synthetic peptide between 27-56 amino acids from the N-terminal region of Human DBH. |
Rabbit Polyclonal Antibody against CD8A (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD8A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 59-88 amino acids from the N-terminal region of human CD8A. |
Active filters
Antibody Hosts
- Rabbit
Isotypes
- Ig
Clonalities
- Polyclonal
Conjugates
- Unconjugated
Families
- Secreted Protein
Filter by
Category
Target Symbol
- TRYPSIN (3)
- ALPHA 2 MACROGLOBULIN (2)
- CA6 (2)
- CALCITONIN (2)
- CD8A (2)
- ENDOTHELIN 1 (2)
- GGH (2)
- GREMLIN 1 (2)
- LIPC (2)
- PROLACTIN (2)
- TNFRSF1A (2)
- VEGFA (2)
- WIF1 (2)
- A1BG (1)
- ADAM23 (1)
- ADAMDEC1 (1)
- ADAMTS10 (1)
- AFM (1)
- AGR3 (1)
- ALPHA 1 ANTITRYPSIN (1)
- ALPHA 1 FETOPROTEIN (1)
- ALPHA LACTALBUMIN (1)
- AMCASE (1)
- AMH (1)
- AMY2B (1)
- ANGIOPOIETIN 1 (1)
- ANGIOPOIETIN 2 (1)
- ANGIOPOIETIN LIKE 4 (1)
- ANGIOPOIETIN LIKE 7 (1)
- APOLIPOPROTEIN A II (1)
- APOLIPOPROTEIN E (1)
- ARMET (1)
- ARSI (1)
- BETA CASEIN (1)
- C1QL3 (1)
- C1QL4 (1)
- C6ORF58 (1)
- CALUMENIN (1)
- CARBOXYPEPTIDASE A2 (1)
- CARDIOTROPHIN 1 (1)
- CART (1)
- CASEIN (1)
- CD130 (1)
- CHORDIN (1)
- CHRDL1 (1)
- CLUSTERIN (1)
- CNDP1 (1)
- COLLAGEN VI (1)
- COMPLEMENT C7 (1)
- COMPLEMENT FACTOR B (1)
- CORTICOTROPIN RELEASING FACTOR (1)
- CPA3 (1)
- CPA6 (1)
- CPN1 (1)
- CREG1 (1)
- CRELD2 (1)
- CSHL1 (1)
- CXCL11 (1)
- DCR3 (1)
- DEFORMED EPIDERMAL AUTOREGULATORY FACTOR 1 (1)
- DERMATOPONTIN (1)
- DKK1 (1)
- DKK3 (1)
- DKK4 (1)
- DOC2A (1)
- DOPAMINE BETA HYDROXYLASE (1)
- EFEMP1 (1)
- EFEMP2 (1)
- EMA (1)
- ENOX2 (1)
- EPO (1)
- EPOR (1)
- EXODUS 2 (1)
- FACTOR D (1)
- FACTOR H (1)
- FACTOR XI (1)
- FACTOR XII (1)
- FAM20C (1)
- FAM5C (1)
- FCN3 (1)
- FETUIN A (1)
- FGF1 (1)
- FGF10 (1)
- FGF16 (1)
- FGF22 (1)
- FGF9 (1)
- FGL1 (1)
- FIBROMODULIN (1)
- FIBULIN 1 (1)
- FSH BETA (1)
- FSTL1 (1)
- FSTL3 (1)
- FUCA2 (1)
- GALANIN (1)
- GALECTIN 10 (1)
- GALECTIN 3 (1)
- GALNT2 (1)
- GCET1 (1)
- GCSF RECEPTOR (1)
- GDF 5 (1)
Reactivities
Assay Types
Pathways
- Cytokine-cytokine receptor interaction (35)
- Jak-STAT signaling pathway (16)
- Pathways in cancer (14)
- MAPK signaling pathway (12)
- Complement and coagulation cascades (11)
- Metabolic pathways (11)
- Neuroactive ligand-receptor interaction (9)
- Wnt signaling pathway (8)
- GnRH signaling pathway (7)
- Hematopoietic cell lineage (7)
- TGF-beta signaling pathway (7)
- Focal adhesion (6)
- Melanoma (6)
- Regulation of actin cytoskeleton (6)
- T cell receptor signaling pathway (5)
- VEGF signaling pathway (5)
- Chemokine signaling pathway (4)
- Fc epsilon RI signaling pathway (4)
- Long-term depression (4)
- Melanogenesis (4)
- Pancreatic cancer (4)
- Renal cell carcinoma (4)
- Toll-like receptor signaling pathway (4)
- Adipocytokine signaling pathway (3)
- Allograft rejection (3)
- Alzheimer's disease (3)
- Arachidonic acid metabolism (3)
- Autoimmune thyroid disease (3)
- Bladder cancer (3)
- Ether lipid metabolism (3)
- Glycerolipid metabolism (3)
- Glycerophospholipid metabolism (3)
- Linoleic acid metabolism (3)
- Vascular smooth muscle contraction (3)
- alpha-Linolenic acid metabolism (3)
- mTOR signaling pathway (3)
- Amyotrophic lateral sclerosis (ALS) (2)
- Antigen processing and presentation (2)
- Apoptosis (2)
- Basal cell carcinoma (2)
- Cell adhesion molecules (CAMs) (2)
- ECM-receptor interaction (2)
- Folate biosynthesis (2)
- Graft-versus-host disease (2)
- Hedgehog signaling pathway (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- NOD-like receptor signaling pathway (2)
- Nitrogen metabolism (2)
- PPAR signaling pathway (2)
- Primary immunodeficiency (2)
- Prion diseases (2)
- RIG-I-like receptor signaling pathway (2)
- Renin-angiotensin system (2)
- Systemic lupus erythematosus (2)
- Type I diabetes mellitus (2)
- Amino sugar and nucleotide sugar metabolism (1)
- Asthma (1)
- Axon guidance (1)
- Cell cycle (1)
- Chronic myeloid leukemia (1)
- Colorectal cancer (1)
- Cytosolic DNA-sensing pathway (1)
- Dilated cardiomyopathy (1)
- Endocytosis (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- ErbB signaling pathway (1)
- Galactose metabolism (1)
- Histidine metabolism (1)
- Natural killer cell mediated cytotoxicity (1)
- O-Glycan biosynthesis (1)
- Other glycan degradation (1)
- SNARE interactions in vesicular transport (1)
- Starch and sucrose metabolism (1)
- Tyrosine metabolism (1)
- beta-Alanine metabolism (1)